SCHEMBL440218

SCHEMBL440218

Cc1cccc(C(=O)c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.61
NPSR1 Q6W5P4 3/20 0.59
ALDH1A1 P00352 2/20 0.59
HTT P42858 2/20 0.59
HPGD P15428 1/20 0.59
CNR1 P21554 1/20 0.58
MAPT P10636 4/20 0.56
POLB P06746 2/20 0.56
CTDSP1 Q9GZU7 1/20 0.56
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPK13 O15264 1/20 0.49
MAPK12 P53778 1/20 0.49
MAPK11 Q15759 1/20 0.49
MAPK14 Q16539 1/20 0.49
GAA P10253 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
EPHX1 P07099 1/20 0.47
VNN1 O95497 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29490805 0.89 CNR2 (0.69) CNR2NPSR1ALDH1A1HTTHPGD
SCHEMBL194537 0.89 CNR2 (0.69) CNR2NPSR1ALDH1A1HTTHPGD
SCHEMBL5606155 0.86 CNR2 (0.66) CNR2NPSR1ALDH1A1HTTHPGD
SCHEMBL20783673 0.85 MAPT (0.59) NPSR1ALDH1A1HTTHPGDMAPT
SCHEMBL29658753 0.83 ATM (0.71) CNR2ALDH1A1CNR1MAPTPOLB
SCHEMBL81347 0.83 ATM (0.71) CNR2ALDH1A1CNR1MAPTPOLB
SCHEMBL12906721 0.82 CNR2 (0.65) CNR2CNR1MAPTPOLBCTDSP1
SCHEMBL6019106 0.82 CNR2 (0.69) CNR2ALDH1A1CNR1MAPTPOLB
SCHEMBL283198 0.82 ATM (0.50) CNR2NPSR1ALDH1A1HTTHPGD
SCHEMBL822041 0.82 PARP1 (0.63) CNR2ALDH1A1HPGDCNR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9564597-B2 Fluorene compound, light-emitting element, light-emitting device, electronic device, lighting device, and organic compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-02-07 US disclosed
US-20150243899-A1 Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-08-27 US disclosed
US-20120061714-A1 Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243899-A1 Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound CYP1A1, CYP1B1, DRD1 CNR2 605/4885NPSR1 1790/4885ALDH1A1 10/4885
US-20120061714-A1 Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound CYP1A1, CYP1B1, DRD1 CNR2 605/4885NPSR1 1790/4885ALDH1A1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.